Sharp Joseph, Wilkinson Lynne, Cox Vivian, Cragg Carol, van Cutsem Gilles, Grimsrud Anna
Emory University School of Medicine, Atlanta, United States.
Médecins Sans Frontières, Cape Town, South Africa.
South Afr J HIV Med. 2019 Jun 11;20(1):905. doi: 10.4102/sajhivmed.v20i1.905. eCollection 2019.
BACKGROUND: Eligibility for differentiated antiretroviral therapy (ART) delivery models has to date been limited to low-risk stable patients. OBJECTIVES: We examined the outcomes of patients who accessed their care and treatment through an ART adherence club (AC), a differentiated ART delivery model, immediately following receiving support to achieve viral suppression after experiencing elevated viral loads (VLs) at a high-burden ART clinic in Khayelitsha, South Africa. METHODS: Beginning in February 2012, patients with VLs above 400 copies/mL either on first- or second-line regimens received a structured intervention developed for patients at risk of treatment failure. Patients who successfully suppressed either on the same regimen or after regimen switch were offered immediate enrolment in an AC facilitated by a lay community health worker. We conducted a retrospective cohort analysis of patients who enrolled in an AC directly after receiving suppression support. We analysed outcomes (retention in care, retention in AC care and viral rebound) using Kaplan-Meier methods with follow-up from October 2012 to June 2015. RESULTS: A total of 165 patients were enrolled in an AC following suppression (81.8% female, median age 36.2 years). At the closure of the study, 119 patients (72.0%) were virally suppressed and 148 patients (89.0%) were retained in care. Six, 12 and 18 months after AC enrolment, retention in care was estimated at 98.0%, 95.0% and 89.0%, respectively. Viral suppression was estimated to be maintained by 90.0%, 84.0% and 75.0% of patients at 6, 12 and 18 months after AC enrolment, respectively. CONCLUSION: Our findings suggest that patients who struggled to achieve or maintain viral suppression in routine clinic care can have good retention and viral suppression outcomes in ACs, a differentiated ART delivery model, following suppression support.
背景:迄今为止,差异化抗逆转录病毒疗法(ART)实施模式的适用对象仅限于低风险稳定患者。 目的:在南非开普敦凯伊利沙高负担ART诊所,我们对那些在病毒载量(VL)升高后获得支持实现病毒抑制后,立即通过ART依从性俱乐部(AC,一种差异化ART实施模式)接受护理和治疗的患者的结局进行了研究。 方法:从2012年2月开始,一线或二线治疗方案中VL高于400拷贝/毫升的患者接受了为有治疗失败风险的患者制定的结构化干预措施。在同一治疗方案或更换治疗方案后成功实现病毒抑制的患者可立即由非专业社区卫生工作者协助加入AC。我们对在获得抑制支持后直接加入AC的患者进行了回顾性队列分析。我们使用Kaplan-Meier方法分析结局(保持治疗、保持AC护理和病毒反弹),随访时间为2012年10月至2015年6月。 结果:共有165名患者在病毒抑制后加入了AC(81.8%为女性,中位年龄36.2岁)。在研究结束时,119名患者(72.0%)实现了病毒抑制,148名患者(89.0%)保持了治疗。加入AC后6个月、12个月和18个月,保持治疗的估计比例分别为98.0%、95.0%和89.0%。加入AC后6个月、12个月和18个月,估计分别有90.0%、84.0%和75.0%的患者维持了病毒抑制。 结论:我们的研究结果表明,在常规诊所护理中难以实现或维持病毒抑制的患者,在获得抑制支持后,采用差异化ART实施模式的AC中可以有良好的保持治疗和病毒抑制结局。
Trop Med Int Health. 2020-12
J Acquir Immune Defic Syndr. 2021-8-1
Trop Med Int Health. 2020-12
J Int AIDS Soc. 2016-12-1